Related Experiment Videos
Comparative study of timolol gel versus timolol solution for patients with glaucoma
1Department of Ophthalmology, Taipei Veterans General Hospital, National Yang-Ming University School of Medicine, Taiwan, ROC.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|November 15, 2000
Summary
Timolol gel, a once-daily glaucoma treatment, effectively maintains intraocular pressure compared to the twice-daily aqueous form. Some patients experienced mild side effects like stickiness with the gel formulation.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Glaucoma management often involves multi-dose eye drops.
- Timolol is a common medication for lowering intraocular pressure.
- A novel gel formulation of timolol was developed to simplify treatment regimens.
Purpose of the Study:
- To compare the efficacy of once-daily timolol gel versus twice-daily timolol aqueous solution in managing intraocular pressure.
- To assess the clinical effects and patient-reported outcomes of two timolol formulations.
Main Methods:
- A 12-week, randomized, open-label, two-period crossover study.
- Fifty-two glaucoma patients were enrolled.
- Patients used either 0.5% timolol gel once daily or 0.5% timolol aqueous solution twice daily for 6 weeks, then switched treatments.
Main Results:
- No statistically significant difference in intraocular pressure (IOP) control was found between the timolol gel and aqueous forms (p>0.05).
- Patients using the timolol gel reported higher incidences of stickiness and transient blurred vision.
- Adverse events were monitored throughout the study.
Conclusions:
- Once-daily timolol gel is a viable alternative for maintaining intraocular pressure in glaucoma patients.
- The gel formulation may offer improved convenience over the twice-daily aqueous form.
- Patient-reported side effects, such as stickiness and blurred vision, should be considered.